Should Investors Cerebras Stock After Monster IPO Debut
Cerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesCerebras burst onto the public market with a splashy IPO, but a strong first day doesn’t guarantee long-term gains. T...
Markets love headlines, but investors need a plan. This guide explains how presidential talk fits into long-term inve...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
A broad market ETF like SCHX hides a sharp concentration at the top. The three largest positions drive about 48% of t...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
Salesforce stock has faced renewed pressure as growth slows and concerns about AI monetization persist. This pragmati...
A hypothetical $10,000 Exxon investment at the outbreak of the Iran conflict has produced a mixed bag of results. Her...
Microsoft stock pulled back early in 2026, turning headlines into a real question for investors: down 15%, should mic...
As volatility lingers in 2026, Realty Income (O) stands out with a steady monthly payout and a long history of divide...
WD-40 has evolved from a single iconic spray into a disciplined maintenance-products company. This deep dive explains...
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...